Context Therapeutics Inc
CNTX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$17.37M
Close$
$0.69
242.7% upside
Current Fair Value
242.7% upsideUndervalued by 242.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $17.37 Million |
|---|---|
| Enterprise Value | $-25,371,027.00 |
| Earnings per Share | $-0.38 |
| Beta | 1.72 |
| Outstanding Shares | 95,183,718 |
Return
| Return on Equity | -120.40% |
|---|---|
| Return on Assets | -99.62% |
| Return on Invested Capital | -126.32% |
Valuation & Multiples
| P/E Ratio | -0.39 |
|---|---|
| PEG | -0.61 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.53 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-0.09
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.09
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 66.21% |
|---|---|
| Total Invested | $3,979▼ 99.99% |
| Investors Holding | 2▼ 79.00% |